Tamoxifen and Cardiac Risk Factors in Healthy Women
نویسندگان
چکیده
منابع مشابه
Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.
-Tamoxifen reduces the incidence of breast cancer in women at risk for that disease. Because heart disease is the leading cause of death in women and because tamoxifen is also associated with venous thrombosis, an improved understanding of the association of tamoxifen with cardiovascular disease risk factors is required. In 111 healthy women at a single center, who were participating in a rando...
متن کاملPractical issues in counseling healthy women about their breast cancer risk and use of tamoxifen citrate.
Advances in the detection and medical and surgical treatment of breast cancer have caught the attention of the media and the public. Such widespread media attention has been a mixed blessing, however; the anxiety engendered may actually lead to poorer compliance with breast cancer screening recommendations and may jeopardize early detection. Despite being better informed, many women seem to fat...
متن کاملproficiency level and factors fostering reticence in efl learners
according to cheng (1999), in recent esl/efl literature, asian (especially east asian) learners of english as a foreign/second language have been arguably reported as reticent and passive learners. the most common allegations are that these students are reluctant to participate in classroom discourse; they are unwilling to give responses; they do not ask questions; and they are passive and over...
15 صفحه اولRisk Factors of Dystocia in Nulliparous Women
Background: Detection of women at risk for dystocia will allow physicians to make preparations and treatment decisions that can minimize maternal and neonatal morbidity. We aimed to determine the risk factors for dystocia in nulliparous women. Methods: This case series enrolled 447 nulliparous women who presented with a single pregnancy in the vertex presentation and gestational age of 38-42 we...
متن کاملBiologic activity of tamoxifen at low doses in healthy women.
BACKGROUND Results of a clinical trial recently completed in the United States indicate that administration of tamoxifen (20 mg/day) to women at risk can reduce breast cancer incidence by approximately 50% but is associated with an increased risk of developing endometrial cancer and venous thromboembolic events. Since these adverse effects may be dose related, we investigated the effect of tamo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arteriosclerosis, Thrombosis, and Vascular Biology
سال: 2001
ISSN: 1079-5642,1524-4636
DOI: 10.1161/01.atv.21.2.255